Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis

MLA

Emma Payne, et al. “Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis.” Clinical Pharmacology and Therapeutics, vol. 108, no. 4, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9151acf0e9377088f2f012de9f37220&authtype=sso&custid=ns315887.

APA

Emma Payne, Julia Spoendlin, Robert J. Glynn, Jessica M. Franklin, Rishi J. Desai, & Sebastian Schneeweiss. (2020). Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis. Clinical Pharmacology and Therapeutics, 108(4).

Chicago

Emma Payne, Julia Spoendlin, Robert J. Glynn, Jessica M. Franklin, Rishi J. Desai, and Sebastian Schneeweiss. 2020. “Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis.” Clinical Pharmacology and Therapeutics 108 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9151acf0e9377088f2f012de9f37220&authtype=sso&custid=ns315887.